| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/1994 | US5328899 NPY peptide analogs |
| 07/12/1994 | US5328898 Factor XIIIA fibrin binding fragments |
| 07/12/1994 | US5328891 DNA codes and proteins |
| 07/12/1994 | US5328842 Compounds, vectors and methods for expressing human, cytosolic phospholipase A2 |
| 07/12/1994 | US5328840 Method for preparing targeted carrier erythrocytes |
| 07/12/1994 | US5328837 Hepatocyte growth factor protease domain variants |
| 07/12/1994 | US5328701 Tissue irrigation solution |
| 07/12/1994 | US5328697 Compositions and processes for the sustained release of drugs |
| 07/12/1994 | US5328694 Stable injectable solution of factor VIII |
| 07/12/1994 | US5328470 Catheter |
| 07/07/1994 | WO1994015211A1 Improved methods for the determination and adjustment of prolactin daily rhythms |
| 07/07/1994 | WO1994014976A1 Immune response modulator complex, and uses thereof |
| 07/07/1994 | WO1994014973A1 Novel neutrophil inhibitors |
| 07/07/1994 | WO1994014962A1 Vaccines against varicella-zoster virus (vzv) |
| 07/07/1994 | WO1994014961A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 07/07/1994 | WO1994014960A2 Protocadherin, their autibodies and uses |
| 07/07/1994 | WO1994014959A1 New protein from urine named component b |
| 07/07/1994 | WO1994014958A1 Synthetic polynucleotides |
| 07/07/1994 | WO1994014956A1 Molecular flashlight |
| 07/07/1994 | WO1994014950A1 Human variant manganese superoxide dismutase |
| 07/07/1994 | WO1994014848A1 Genetically engineered immunoglobulins |
| 07/07/1994 | WO1994014847A1 Genetically engineered immunoglobulins |
| 07/07/1994 | WO1994014846A1 Assay and treatment for demyelinating diseases such as multiple sclerosis |
| 07/07/1994 | WO1994014845A1 Modified tcf |
| 07/07/1994 | WO1994014843A1 Endothelin antagonists |
| 07/07/1994 | WO1994014842A1 Difluoro-pentapeptide derivative anti-inflammatory agents |
| 07/07/1994 | WO1994014841A1 Lhrh antagonists having modified aminoacyl residues at postions 5 and 6 |
| 07/07/1994 | WO1994014840A1 Acyclic peptide analogs of the atrial natriuretic peptide, process for producing the same and their use |
| 07/07/1994 | WO1994014839A1 Acyclic, sulphureous peptides as analogs of the atrial natriuretic peptide |
| 07/07/1994 | WO1994014838A1 Antibiotics ge 37468 a, b and c |
| 07/07/1994 | WO1994014837A1 Purification of proteinaceous material |
| 07/07/1994 | WO1994014836A1 Peptide inhibitors of selectin binding |
| 07/07/1994 | WO1994014775A1 Platelet aggregation inhibiting compounds |
| 07/07/1994 | WO1994014475A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT |
| 07/07/1994 | WO1994014474A1 Restoration of immunological function in asymptomatic hiv-positive patients |
| 07/07/1994 | WO1994014473A1 Therapeutic combination containing interferon |
| 07/07/1994 | WO1994014472A1 Method for inhibition of cell adhesion to receptors containing selectins |
| 07/07/1994 | WO1994014471A1 Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator |
| 07/07/1994 | WO1994014468A1 Improved peritoneal dialysis solutions with polypeptides |
| 07/07/1994 | WO1994014467A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/07/1994 | WO1994014466A1 Aqueous pharmaceutical preparations of g-csf with a long shelf life |
| 07/07/1994 | WO1994014465A1 Stable lyophilized pharmaceutical preparations g-csf |
| 07/07/1994 | WO1994014464A1 Synergistic compositions containing an antiviral nucleoside analogue and an antiviral oligopeptide |
| 07/07/1994 | WO1994014463A1 Compositions and method for the inhibition of phagocytes |
| 07/07/1994 | WO1994014462A1 Method of retarding the progression of chronic renal failure |
| 07/07/1994 | WO1994014461A1 Insulin analogs |
| 07/07/1994 | WO1994014460A1 Method for crosslinking of haemoglobin and use of such crosslinked haemoglobin |
| 07/07/1994 | WO1994014459A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
| 07/07/1994 | WO1994014454A1 Vaccines against sterols |
| 07/07/1994 | WO1994014437A1 Prevention and treatment of sepsis |
| 07/07/1994 | WO1994014436A1 Retroviral protease inhibiting compounds |
| 07/07/1994 | WO1994014347A1 A protective garment |
| 07/07/1994 | WO1994011512A3 Allergenic proteins and peptides from japanese cedar pollen |
| 07/07/1994 | WO1994011509A3 Peptides and anti-sense peptides with broad neoplastic specificity |
| 07/07/1994 | WO1994011508A3 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
| 07/07/1994 | WO1994011503A3 Chimeric factor viii |
| 07/07/1994 | WO1994011502A3 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 07/07/1994 | WO1994010207A3 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 07/07/1994 | WO1994005791A3 Dorsal tissue affecting factor and compositions |
| 07/07/1994 | WO1993022433A3 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |
| 07/07/1994 | DE4244639A1 Medicament or medicament composition |
| 07/07/1994 | DE4244565A1 Lymphocytoma proliferation activating peptide structure and peptide |
| 07/07/1994 | CA2152599A1 Novel neutrophil inhibitors |
| 07/07/1994 | CA2152508A1 Improved methods for the determination and adjustment of prolactin daily rhythms |
| 07/07/1994 | CA2152389A1 Therapeutic combination containing interferon |
| 07/07/1994 | CA2152256A1 Vaccines against varicella-zoster virus (vzv) |
| 07/07/1994 | CA2151961A1 Acyclic peptide analogs of the atrial natriuretic peptide, process for producing the same and their use |
| 07/07/1994 | CA2151959A1 Acyclic, sulphureous peptides as analogs of the atrial natriuretic peptide |
| 07/07/1994 | CA2151616A1 Antibiotics ge 37468 a, b and c |
| 07/07/1994 | CA2151386A1 Prevention and treatment of sepsis |
| 07/07/1994 | CA2151156A1 New protein from urine named component b |
| 07/07/1994 | CA2151134A1 Insulin analogs |
| 07/07/1994 | CA2146874A1 Endothelin antagonists |
| 07/07/1994 | CA2136079A1 Lhrh antagonists having modified aminoacyl residues at positions 5 and 6 |
| 07/07/1994 | CA2130561A1 Modified tcf |
| 07/07/1994 | CA2129991A1 Improved peritoneal dialysis solutions with polypeptides |
| 07/06/1994 | EP0605219A1 Products containing active milk protein components and process for producing the same |
| 07/06/1994 | EP0604957A1 2-Amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
| 07/06/1994 | EP0604945A1 TAN-1511, its derivatives, production and use thereof |
| 07/06/1994 | EP0604802A1 Anticariogenic foodstuff |
| 07/06/1994 | EP0604744A2 Method for treating systemic inflammatory response syndrome |
| 07/06/1994 | EP0604727A1 Improved immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen |
| 07/06/1994 | EP0604706A1 Production of human parathyroid hormone from microorganisms |
| 07/06/1994 | EP0604684A1 Process for the recovery of alpha-lactalbumin and beta-lactoglobulin from a whey protein product |
| 07/06/1994 | EP0604647A1 Alleviation of symptoms associated with inflammatory disease states |
| 07/06/1994 | EP0604624A1 Multimeric forms of human rhinovirus receptor protein |
| 07/06/1994 | EP0604605A1 Treating disorders by application of insulin-like growth factors and analogs |
| 07/06/1994 | EP0604603A1 Cadherin materials and methods |
| 07/06/1994 | EP0604584A1 Factors for the cellular functional regulation and biological applications thereof |
| 07/06/1994 | EP0604560A1 Human cyclin e |
| 07/06/1994 | EP0604488A1 Polypeptides, inhibitors of the replication of hsu and similar viruses |
| 07/06/1994 | EP0604459A1 Organic nitrates, methods for preparing same and use thereof for treating cardiovascular diseases |
| 07/06/1994 | EP0604453A1 Disease associated b-cell epitopes of tpo and use thereof |
| 07/06/1994 | EP0604433A1 Composition and method for disease treatment |
| 07/06/1994 | EP0604418A1 Isolated viral protein cytokine antagonists |
| 07/06/1994 | EP0604416A1 Identifying membranolytic compounds and precursors thereof |
| 07/06/1994 | EP0604409A1 Compositions and methods for detecting and modulating rna activity and gene expression |
| 07/06/1994 | EP0579747A4 Method of modulating mammalian t-cell response |
| 07/06/1994 | EP0324788B1 Peptide fragment capable of binding to laminin |
| 07/06/1994 | EP0205475B1 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |